Nelly G. Adel

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center

Troy Z. Horvat, Nelly G. Adel, Thu-Oanh Dang et al. · Journal of Clinical Oncology · 2015 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +17

High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis

Russell Moore, Nelly G. Adel, Elyn Riedel et al. · Journal of Clinical Oncology · 2011 · 432 citations · Full text

Medicine, Hematology, Oncology +16

Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death

Jessica K. Altman, Alfred Rademaker, Elizabeth H. Cull et al. · Leukemia Research · 2013 · 134 citations

Medicine, Hematology, Oncology +11

Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies.

Nelly G. Adel · PubMed · 2017 · 111 citations

Medicine, Pharmacology, Pharmacotherapy +16

Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia

Samantha Reiss, Larry W. Buie, Nelly G. Adel et al. · Annals of Hematology · 2016 · 64 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +5